Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Exp Med ; 194(6): 847-53, 2001 Sep 17.
Article in English | MEDLINE | ID: mdl-11560999

ABSTRACT

Chemokines dictate regional trafficking of functionally distinct T cell subsets. In rodents and humans, a unique subset of CD4(+)CD25(+) cytotoxic T lymphocyte antigen (CTLA)-4(+) regulatory T cells (Treg) has been proposed to control peripheral tolerance. However, the molecular basis of immune suppression and the trafficking properties of Treg cells are still unknown. Here, we determined the chemotactic response profile and chemokine receptor expression of human blood-borne CD4(+)CD25(+) Treg cells. These Treg cells were found to vigorously respond to several inflammatory and lymphoid chemokines. Treg cells specifically express the chemokine receptors CCR4 and CCR8 and represent a major subset of circulating CD4(+) T cells responding to the chemokines macrophage-derived chemokine (MDC)/CCL22, thymus and activation-regulated chemokine (TARC)/CCL17, I-309/CCL1, and to the virokine vMIP-I (ligands of CCR4 and CCR8). Blood-borne CD4(+) T cells that migrate in response to CCL1 and CCL22 exhibit a reduced alloproliferative response, dependent on the increased frequency of Treg cells in the migrated population. Importantly, mature dendritic cells preferentially attract Treg cells among circulating CD4(+) T cells, by secretion of CCR4 ligands CCL17 and CCL22. Overall, these results suggest that CCR4 and/or CCR8 may guide Treg cells to sites of antigen presentation in secondary lymphoid tissues and inflamed areas to attenuate T cell activation.


Subject(s)
CD4-Positive T-Lymphocytes/physiology , Chemokines, CC/metabolism , Chemotaxis/physiology , Immunoconjugates , Receptors, Chemokine/biosynthesis , Receptors, Interleukin-2 , Abatacept , Antigens, CD , Antigens, Differentiation , Biomarkers , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/metabolism , CTLA-4 Antigen , Cells, Cultured , Chemokine CCL1 , Chemokine CCL17 , Chemokine CCL19 , Chemokine CCL20 , Chemokine CCL22 , Chemokine CXCL11 , Chemokines, CC/pharmacology , Chemokines, CXC/metabolism , Chemokines, CXC/pharmacology , Humans , Macrophage Inflammatory Proteins/metabolism , Macrophage Inflammatory Proteins/pharmacology , Receptors, CCR4 , Receptors, CCR6 , Receptors, CCR8
2.
Eur J Immunol ; 30(4): 1030-9, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10760790

ABSTRACT

Th1 and Th2 cells, which produce distinct sets of cytokines, differentially express several chemokine receptors that may regulate their tissue-specific localization. Although the expression pattern and regulation of chemokines are likely to play a critical role in many immunopathological processes, they remain largely unknown. Here, we investigated the requirements for Th1 and Th2 cells to produce the Th2 cell-attracting chemokines thymus and activation-regulated chemokine (TARC), macrophage-derived chemokine (MDC) and I-309. TCR triggering of Th1 and Th2 cells leads to production of MDC and I-309 (CCR4 and CCR8 ligands, respectively), whereas TARC (CCR4 ligand) is selectively produced by Th2 cells. Secretion of these chemokines appears to be independent of endogenous production of IL-4 and IFN-gamma. IL-12 and IFN-alpha, cytokines that promote the differentiation of human Th1 cells, selectively inhibit secretion and mRNA expression of MDC and I-309 by Th1 cells. Suppression of I-309 secretion results in a decreased chemotactic effect on L1.2 cells transfected with human CCR8, indicating that IL-12 and IFN-alpha may inhibit the recruitment of CCR8-expressing cells such as Th2 cells. The inhibition of Th2 cell-attracting chemokines MDC and I-309 illustrates a novel mechanism by which IL-12 and IFN-alpha could promote and maintain an ongoing Th1 response.


Subject(s)
Chemokines, CC/biosynthesis , Interferon-alpha/pharmacology , Interleukin-12/pharmacology , Receptors, Antigen, T-Cell/immunology , Th1 Cells/metabolism , Animals , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Cell Differentiation/drug effects , Cell Line , Cells, Cultured , Chemokine CCL1 , Chemokine CCL17 , Chemokine CCL22 , Chemokines, CC/antagonists & inhibitors , Chemokines, CC/genetics , Chemokines, CC/metabolism , Chemotaxis, Leukocyte/drug effects , Chemotaxis, Leukocyte/immunology , Dose-Response Relationship, Drug , Humans , Interferon-alpha/metabolism , Interferon-gamma/analysis , Interferon-gamma/physiology , Interleukin-12/metabolism , Interleukin-4/analysis , Interleukin-4/physiology , Ligands , Lymphocyte Activation , Mice , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, CCR4 , Receptors, CCR8 , Receptors, Chemokine/genetics , Receptors, Chemokine/immunology , Receptors, Chemokine/metabolism , Th1 Cells/cytology , Th1 Cells/drug effects , Th1 Cells/immunology , Th2 Cells/drug effects , Th2 Cells/immunology , Th2 Cells/metabolism , Transfection
4.
Blood ; 94(9): 2981-9, 1999 Nov 01.
Article in English | MEDLINE | ID: mdl-10556180

ABSTRACT

CD4(+) T helper 1 (Th1) cells and Th2 cells are distinguished based on the pattern of cytokines they are able to produce. Selectin ligands and chemokine receptors are differentially expressed in Th1 and Th2 cells, providing a basis for tissue-specific recruitment of helper T-cell subsets. However, the modes and mechanisms regulating tissue-specific localization of Th1 and Th2 cells are still largely unknown. Here, we show the preferential expression on Th1 cells of the integrin alpha6/beta1, which is distinctly regulated by the Th1-inducing cytokines interleukin-12 (IL-12) and interferon-alfa (IFN-alpha). The pattern of integrin alpha6/beta1 regulation closely mirrors that of the chemokine receptor CCR1. Analysis of signal transducer and activator of transcription 4 (Stat4) activation by IL-12 and IFN-alpha shows distinct signaling kinetics by these cytokines, correlating with the pattern of CCR1 and integrin alpha6/beta1 expression. Unlike IFN-alpha, the ability of IL-12 to generate prolonged intracellular signals appears to be critical for inducing integrin alpha6/beta1 upregulation in Th1 cells. The expression and upregulation of CCR1 and alpha6/beta1 integrin promotes the migration of Th1 cells. These findings suggest that the exquisite regulation of integrin alpha6/beta1 and CCR1 may play an important role in tissue-specific localization of Th1 cells.


Subject(s)
Adjuvants, Immunologic/pharmacology , Cell Movement/physiology , Integrins/physiology , Interleukin-12/pharmacology , Receptors, Chemokine/physiology , Th1 Cells/pathology , Th1 Cells/physiology , Cell Movement/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Integrin alpha6beta1 , Receptors, CCR1 , Signal Transduction/drug effects , Signal Transduction/physiology , Up-Regulation/drug effects
5.
J Immunol ; 161(10): 5111-5, 1998 Nov 15.
Article in English | MEDLINE | ID: mdl-9820476

ABSTRACT

Polarized Th1 and Th2 cells differentially express adhesion molecules and chemokine receptors, endowing these cells with distinct tissue homing capabilities. Here we report that, in contrast to other chemokine receptors, the expression of CCR4 and CCR8 on Th2 cells is transiently increased following TCR and CD28 engagement. IL-4 is not required for this activation-induced up-regulation of CCR4 and CCR8. In accordance with receptor expression, the response of Th2 cells to I-309 (CCR8 ligand) and thymus- and activation-regulated chemokine (CCR4 and CCR8 ligand) is enhanced upon activation. Moreover, activated Th1 cells up-regulate CCR4 expression and functional responsiveness to thymus- and activation-regulated chemokine. Analysis of polarized subsets of CD8+ T cells reveals a similar pattern of chemokine receptor expression and modulation of responsiveness. Taken together, these findings suggest that an up-regulation of CCR4 and CCR8 following Ag encounter may contribute to the proper positioning of activated T cells within sites of antigenic challenge and/or specialized areas of lymphoid tissues.


Subject(s)
Lymphocyte Activation , Receptors, Chemokine/metabolism , Th2 Cells/metabolism , Up-Regulation/immunology , Calcium/metabolism , Cell Line , Cell Movement/immunology , Cell Polarity/immunology , Clone Cells , Fetal Blood , Humans , Intracellular Fluid/metabolism , Receptors, CCR4 , Receptors, CCR8 , Th1 Cells/immunology , Th1 Cells/metabolism , Th2 Cells/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...